 CAMBRIDGE, Mass., July 07, 2021 GLOBE NEWSWIRE -- Jounce Therapeutics, Inc. NASDAQ: JNCE, a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced that Dmitri Wiederschain, Ph.D., Chief Scientific Officer will participate in a panel discussion at the William Blairs Biotech Focus Conference taking place virtually on Wednesday, July 14, 2021 at 4:20 PM ET. 